Unconditional FDA Approval of the STAR Trial (Siegel Transcatheter Aortic Valve Replacement in patients with symptomatic severe aortic stenosis)

11/25/2025 MiRus receives unconditional FDA approval for the STAR Trial RCT of the Siegel TAVR. The post Unconditional FDA Approval of the STAR Trial (Siegel Transcatheter Aortic Valve Replacement in patients with symptomatic severe aortic stenosis) appeared first on MiRus .